| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |